GrippeCanadaV3, Main, Exploration, bibRecord, 000001

Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.

Identifieur interne : 000001 ( Main/Exploration ); précédent : 000000; suivant : 000002

Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.

Auteurs : Imran Satia [Canada, Royaume-Uni] ; Ruth Cusack [Canada] ; Justina M. Greene [Canada] ; Paul M. O'Byrne [Canada] ; Kieran J. Killian [Canada] ; Neil Johnston [Canada]

Source :

PloS one [ 1932-6203 ] ; 2020.

RBID : pubmed:32027687

Descripteurs français

English descriptors

KwdEn :
- Asthma (complications), Asthma (epidemiology), Community-Acquired Infections (epidemiology), Emergency Service, Hospital (statistics & numerical data), History, 21st Century, Hospitalization (statistics & numerical data), Hospitalization (trends), Humans, Ontario (epidemiology), Prevalence, Pulmonary Disease, Chronic Obstructive (complications), Pulmonary Disease, Chronic Obstructive (epidemiology), Respiratory Tract Infections (epidemiology), Retrospective Studies, Virus Diseases (epidemiology).
MESH :
- geographic , epidemiology : Ontario.
- complications : Asthma, Pulmonary Disease, Chronic Obstructive.
- epidemiology : Asthma, Community-Acquired Infections, Pulmonary Disease, Chronic Obstructive, Respiratory Tract Infections, Virus Diseases.
- statistics & numerical data : Emergency Service, Hospital, Hospitalization.
- trends : Hospitalization.
- History, 21st Century, Humans, Prevalence, Retrospective Studies.

Abstract

BACKGROUND

The individual and combined contribution of viral prevalence in the community to Emergency Department (ED) visits and hospitalizations with respiratory tract infections (RTIs), chronic obstructive pulmonary disease (COPD) and asthma is unclear.

METHODS

A retrospective analysis on daily viral positive tests and daily ED visits and hospitalizations between 01/01/2003 to 31/12/2013 in Ontario, Canada. Viral data was collected from the Centre for Immunization and Respiratory Infectious Diseases (CIRID). The Canadian Institute for Health Information reports daily ED visits and hospitalizations for RTIs, COPD and asthma as a primary diagnosis.

RESULTS

There were 4,365,578 ED visits with RTIs of which 321,719 (7.4%) were admitted to hospital; 817,141 ED visits for COPD of which 260,665 (31.9%) were admitted and 649,666 ED visits with asthma of which 68,626 (10.6%) were admitted. The percentage of positive tests to influenza A and B, respiratory syncytial virus (RSV), parainfluenza and adenovirus prevalence explained 57.4% of ED visits and 63.8% of hospitalizations for RTI, 41.4% of ED visits and 39.2% of hospitalizations with COPD but only 1.5% of ED visits and 2.7% of hospitalizations for asthma. The further addition of human metapneumovirus, rhinovirus and coronavirus over the final 3 years accounted for 66.7% of ED visits and 74.4% of hospitalizations for RTI, 52.5% of visits and 48.2% of hospitalizations for COPD, and only 13.3% of visits and 10.4% of hospitalizations for asthma.

CONCLUSIONS

Community respiratory viral epidemics are major drivers of ED visits and hospitalizations with RTIs and COPD but only a modest contributor to asthma.

DOI: 10.1371/journal.pone.0228544
PubMed: 32027687

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000000
to stream Main, to step Curation: 000000

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.</title>
<author><name sortKey="Satia, Imran" sort="Satia, Imran" uniqKey="Satia I" first="Imran" last="Satia">Imran Satia</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester</wicri:regionArea>
<placeName><settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author><name sortKey="Cusack, Ruth" sort="Cusack, Ruth" uniqKey="Cusack R" first="Ruth" last="Cusack">Ruth Cusack</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Greene, Justina M" sort="Greene, Justina M" uniqKey="Greene J" first="Justina M" last="Greene">Justina M. Greene</name>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Byrne, Paul M" sort="O Byrne, Paul M" uniqKey="O Byrne P" first="Paul M" last="O'Byrne">Paul M. O'Byrne</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Killian, Kieran J" sort="Killian, Kieran J" uniqKey="Killian K" first="Kieran J" last="Killian">Kieran J. Killian</name>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Johnston, Neil" sort="Johnston, Neil" uniqKey="Johnston N" first="Neil" last="Johnston">Neil Johnston</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32027687</idno>
<idno type="pmid">32027687</idno>
<idno type="doi">10.1371/journal.pone.0228544</idno>
<idno type="wicri:Area/Main/Corpus">000000</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000000</idno>
<idno type="wicri:Area/Main/Curation">000000</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000000</idno>
<idno type="wicri:Area/Main/Exploration">000000</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.</title>
<author><name sortKey="Satia, Imran" sort="Satia, Imran" uniqKey="Satia I" first="Imran" last="Satia">Imran Satia</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:affiliation>University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, United Kingdom.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester</wicri:regionArea>
<placeName><settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author><name sortKey="Cusack, Ruth" sort="Cusack, Ruth" uniqKey="Cusack R" first="Ruth" last="Cusack">Ruth Cusack</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Greene, Justina M" sort="Greene, Justina M" uniqKey="Greene J" first="Justina M" last="Greene">Justina M. Greene</name>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="O Byrne, Paul M" sort="O Byrne, Paul M" uniqKey="O Byrne P" first="Paul M" last="O'Byrne">Paul M. O'Byrne</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Killian, Kieran J" sort="Killian, Kieran J" uniqKey="Killian K" first="Kieran J" last="Killian">Kieran J. Killian</name>
<affiliation wicri:level="1"><nlm:affiliation>McMaster University Department of Medicine, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>McMaster University Department of Medicine, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Johnston, Neil" sort="Johnston, Neil" uniqKey="Johnston N" first="Neil" last="Johnston">Neil Johnston</name>
<affiliation wicri:level="1"><nlm:affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton</wicri:regionArea>
<wicri:noRegion>Hamilton</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Asthma (complications)</term>
<term>Asthma (epidemiology)</term>
<term>Community-Acquired Infections (epidemiology)</term>
<term>Emergency Service, Hospital (statistics & numerical data)</term>
<term>History, 21st Century</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Hospitalization (trends)</term>
<term>Humans</term>
<term>Ontario (epidemiology)</term>
<term>Prevalence</term>
<term>Pulmonary Disease, Chronic Obstructive (complications)</term>
<term>Pulmonary Disease, Chronic Obstructive (epidemiology)</term>
<term>Respiratory Tract Infections (epidemiology)</term>
<term>Retrospective Studies</term>
<term>Virus Diseases (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Asthme ()</term>
<term>Asthme (épidémiologie)</term>
<term>Broncho-pneumopathie chronique obstructive ()</term>
<term>Broncho-pneumopathie chronique obstructive (épidémiologie)</term>
<term>Histoire du 21ème siècle</term>
<term>Hospitalisation ()</term>
<term>Hospitalisation (tendances)</term>
<term>Humains</term>
<term>Infections communautaires (épidémiologie)</term>
<term>Infections de l'appareil respiratoire (épidémiologie)</term>
<term>Maladies virales (épidémiologie)</term>
<term>Ontario (épidémiologie)</term>
<term>Prévalence</term>
<term>Service hospitalier d'urgences ()</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ontario</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Asthma</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Asthma</term>
<term>Community-Acquired Infections</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
<term>Respiratory Tract Infections</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Emergency Service, Hospital</term>
<term>Hospitalization</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Hospitalisation</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Hospitalization</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Infections communautaires</term>
<term>Infections de l'appareil respiratoire</term>
<term>Maladies virales</term>
<term>Ontario</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>History, 21st Century</term>
<term>Humans</term>
<term>Prevalence</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
<term>Histoire du 21ème siècle</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Prévalence</term>
<term>Service hospitalier d'urgences</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>The individual and combined contribution of viral prevalence in the community to Emergency Department (ED) visits and hospitalizations with respiratory tract infections (RTIs), chronic obstructive pulmonary disease (COPD) and asthma is unclear.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>A retrospective analysis on daily viral positive tests and daily ED visits and hospitalizations between 01/01/2003 to 31/12/2013 in Ontario, Canada. Viral data was collected from the Centre for Immunization and Respiratory Infectious Diseases (CIRID). The Canadian Institute for Health Information reports daily ED visits and hospitalizations for RTIs, COPD and asthma as a primary diagnosis.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>There were 4,365,578 ED visits with RTIs of which 321,719 (7.4%) were admitted to hospital; 817,141 ED visits for COPD of which 260,665 (31.9%) were admitted and 649,666 ED visits with asthma of which 68,626 (10.6%) were admitted. The percentage of positive tests to influenza A and B, respiratory syncytial virus (RSV), parainfluenza and adenovirus prevalence explained 57.4% of ED visits and 63.8% of hospitalizations for RTI, 41.4% of ED visits and 39.2% of hospitalizations with COPD but only 1.5% of ED visits and 2.7% of hospitalizations for asthma. The further addition of human metapneumovirus, rhinovirus and coronavirus over the final 3 years accounted for 66.7% of ED visits and 74.4% of hospitalizations for RTI, 52.5% of visits and 48.2% of hospitalizations for COPD, and only 13.3% of visits and 10.4% of hospitalizations for asthma.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>Community respiratory viral epidemics are major drivers of ED visits and hospitalizations with RTIs and COPD but only a modest contributor to asthma.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32027687</PMID>
<DateCompleted><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>15</Volume>
<Issue>2</Issue>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.</ArticleTitle>
<Pagination><MedlinePgn>e0228544</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0228544</ELocationID>
<Abstract><AbstractText Label="BACKGROUND">The individual and combined contribution of viral prevalence in the community to Emergency Department (ED) visits and hospitalizations with respiratory tract infections (RTIs), chronic obstructive pulmonary disease (COPD) and asthma is unclear.</AbstractText>
<AbstractText Label="METHODS">A retrospective analysis on daily viral positive tests and daily ED visits and hospitalizations between 01/01/2003 to 31/12/2013 in Ontario, Canada. Viral data was collected from the Centre for Immunization and Respiratory Infectious Diseases (CIRID). The Canadian Institute for Health Information reports daily ED visits and hospitalizations for RTIs, COPD and asthma as a primary diagnosis.</AbstractText>
<AbstractText Label="RESULTS">There were 4,365,578 ED visits with RTIs of which 321,719 (7.4%) were admitted to hospital; 817,141 ED visits for COPD of which 260,665 (31.9%) were admitted and 649,666 ED visits with asthma of which 68,626 (10.6%) were admitted. The percentage of positive tests to influenza A and B, respiratory syncytial virus (RSV), parainfluenza and adenovirus prevalence explained 57.4% of ED visits and 63.8% of hospitalizations for RTI, 41.4% of ED visits and 39.2% of hospitalizations with COPD but only 1.5% of ED visits and 2.7% of hospitalizations for asthma. The further addition of human metapneumovirus, rhinovirus and coronavirus over the final 3 years accounted for 66.7% of ED visits and 74.4% of hospitalizations for RTI, 52.5% of visits and 48.2% of hospitalizations for COPD, and only 13.3% of visits and 10.4% of hospitalizations for asthma.</AbstractText>
<AbstractText Label="CONCLUSIONS">Community respiratory viral epidemics are major drivers of ED visits and hospitalizations with RTIs and COPD but only a modest contributor to asthma.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Satia</LastName>
<ForeName>Imran</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0003-4206-6000</Identifier>
<AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>University of Manchester, Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cusack</LastName>
<ForeName>Ruth</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>McMaster University Department of Medicine, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Greene</LastName>
<ForeName>Justina M</ForeName>
<Initials>JM</Initials>
<AffiliationInfo><Affiliation>McMaster University Department of Medicine, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>O'Byrne</LastName>
<ForeName>Paul M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>McMaster University Department of Medicine, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Killian</LastName>
<ForeName>Kieran J</ForeName>
<Initials>KJ</Initials>
<AffiliationInfo><Affiliation>McMaster University Department of Medicine, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Johnston</LastName>
<ForeName>Neil</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>02</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>IS reports grant from the ERS RESPIRE3 Marie Curie Award, BMA James Trust Award, North West Lung Centre Grant, personal fees from Merck MSD, AstraZenca, GSK, sponsorship to attend conference meetings, outside the submitted work; RC, JMG, KJK, NJ have no disclosures. PMO reports personal fees from oversight committee for LABA safety study, consulting fees from AstraZeneca, GSK, Merck, Boehringer, grants from AstraZeneca, Genentech, outside the submitted work. The research reported in this article was funded by an unrestricted grant from AstraZeneca Canada to PMO with no input in data collection, analysis, interpretation or writing of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>11</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>01</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>2</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>2</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32027687</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0228544</ArticleId>
<ArticleId IdType="pii">PONE-D-19-31523</ArticleId>
<ArticleId IdType="pmc">PMC7004370</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Clin Virol. 2014 Oct;61(2):181-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25066886</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2012 Nov 1;186(9):886-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22923659</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1996 Nov 2;313(7065):1119-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8916700</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Allergy Clin Immunol. 2005 Jan;115(1):132-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15637559</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2012 Sep 1;206(5):628-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22723641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2010 May 1;375(9725):1545-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20399493</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 1974 Jan 21;227(3):292-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4358170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pediatr. 1973 Apr;82(4):578-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">4349062</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ther Adv Respir Dis. 2016 Apr;10(2):158-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26611907</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1993 Oct 16;307(6910):982-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8241910</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chest. 2013 Aug;144(2):507-514</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23519329</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1995 May 13;310(6989):1225-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7767192</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Allergy Clin Immunol. 2004 Aug;114(2):239-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15316497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2005 May;50(4):322-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15845430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11719299</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Virol. 2018 Apr;163(4):845-853</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29327237</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S115-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26595727</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2010 Sep 4;376(9743):826-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20816549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Mol Sci. 2017 Jan 26;18(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28134768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2015 Jan;135(1):e24-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25489019</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Exp Allergy. 1992 Mar;22(3):325-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1586873</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Am Thorac Soc. 2005;2(4):361-6; discussion 371-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16267363</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Influenza Other Respir Viruses. 2013 Jan;7(1):35-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22405488</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pediatr. 1979 Aug;95(2):183-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">448557</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 1997 Oct 18;315(7114):1012</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9365305</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Manchester</li>
</region>
<settlement><li>Manchester</li>
</settlement>
<orgName><li>Université de Manchester</li>
</orgName>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Satia, Imran" sort="Satia, Imran" uniqKey="Satia I" first="Imran" last="Satia">Imran Satia</name>
</noRegion>
<name sortKey="Cusack, Ruth" sort="Cusack, Ruth" uniqKey="Cusack R" first="Ruth" last="Cusack">Ruth Cusack</name>
<name sortKey="Cusack, Ruth" sort="Cusack, Ruth" uniqKey="Cusack R" first="Ruth" last="Cusack">Ruth Cusack</name>
<name sortKey="Greene, Justina M" sort="Greene, Justina M" uniqKey="Greene J" first="Justina M" last="Greene">Justina M. Greene</name>
<name sortKey="Johnston, Neil" sort="Johnston, Neil" uniqKey="Johnston N" first="Neil" last="Johnston">Neil Johnston</name>
<name sortKey="Killian, Kieran J" sort="Killian, Kieran J" uniqKey="Killian K" first="Kieran J" last="Killian">Kieran J. Killian</name>
<name sortKey="O Byrne, Paul M" sort="O Byrne, Paul M" uniqKey="O Byrne P" first="Paul M" last="O'Byrne">Paul M. O'Byrne</name>
<name sortKey="O Byrne, Paul M" sort="O Byrne, Paul M" uniqKey="O Byrne P" first="Paul M" last="O'Byrne">Paul M. O'Byrne</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Satia, Imran" sort="Satia, Imran" uniqKey="Satia I" first="Imran" last="Satia">Imran Satia</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000001 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000001 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeCanadaV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32027687
   |texte=   Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32027687" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 13:36:58 2020. Site generation: Sat Sep 26 07:06:42 2020

	Corpus GrippeCanadaV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeCanadaV3

Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.

Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki